|
Esophageal Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
To explore the anti-tumor effects of esophageal cancer-related gene 2 (ECRG2) in combination with cisplatin (DDP) in DDP-resistant esophageal cancer cells (EC9706/DDP).
|
28348485 |
2017 |
|
Esophageal carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
To explore the anti-tumor effects of esophageal cancer-related gene 2 (ECRG2) in combination with cisplatin (DDP) in DDP-resistant esophageal cancer cells (EC9706/DDP).
|
28348485 |
2017 |
|
Malignant neoplasm of esophagus
|
0.100 |
Biomarker
|
disease |
BEFREE |
These findings suggest that the combination of ECRG2 and DDP may be a promising strategy for the clinical treatment of esophageal cancers that are resistant to DDP.
|
28348485 |
2017 |
|
Esophageal Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin.
|
24606472 |
2014 |
|
Esophageal carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin.
|
24606472 |
2014 |
|
Malignant neoplasm of esophagus
|
0.100 |
Biomarker
|
disease |
BEFREE |
Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin.
|
24606472 |
2014 |
|
Esophageal Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
A short tandem repeat (STR) polymorphism in the 3'UTR region of esophageal cancer-related gene 2 (ECRG2, also known as SPINK7) has been widely reported to be associated with the incidence and the prognosis of esophageal squamous cell carcinoma (ESCC).
|
22315007 |
2013 |
|
Esophageal carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
A short tandem repeat (STR) polymorphism in the 3'UTR region of esophageal cancer-related gene 2 (ECRG2, also known as SPINK7) has been widely reported to be associated with the incidence and the prognosis of esophageal squamous cell carcinoma (ESCC).
|
22315007 |
2013 |
|
Malignant neoplasm of esophagus
|
0.100 |
Biomarker
|
disease |
BEFREE |
A short tandem repeat (STR) polymorphism in the 3'UTR region of esophageal cancer-related gene 2 (ECRG2, also known as SPINK7) has been widely reported to be associated with the incidence and the prognosis of esophageal squamous cell carcinoma (ESCC).
|
22315007 |
2013 |
|
Esophageal Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Esophageal cancer-related gene 2 (ECRG2) is found to be critical in the process of carcinogenesis.
|
23079671 |
2012 |
|
Esophageal carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Esophageal cancer-related gene 2 (ECRG2) is found to be critical in the process of carcinogenesis.
|
23079671 |
2012 |
|
Malignant neoplasm of esophagus
|
0.100 |
Biomarker
|
disease |
BEFREE |
Esophageal cancer-related gene 2 (ECRG2) is found to be critical in the process of carcinogenesis.
|
23079671 |
2012 |
|
Esophageal Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
However, ECRG2 gene was significantly down-regulated in primary esophageal cancer tissues.
|
21042721 |
2010 |
|
Esophageal carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
However, ECRG2 gene was significantly down-regulated in primary esophageal cancer tissues.
|
21042721 |
2010 |
|
Malignant neoplasm of esophagus
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
However, ECRG2 gene was significantly down-regulated in primary esophageal cancer tissues.
|
21042721 |
2010 |
|
Esophageal Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Short tandem repeat (STR) polymorphisms in exon 4 of esophageal cancer related gene 2 (ECRG2) are a prognostic marker for squamous cell carcinoma (SCC) of the esophagus.
|
17418617 |
2008 |
|
Esophageal carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Short tandem repeat (STR) polymorphisms in exon 4 of esophageal cancer related gene 2 (ECRG2) are a prognostic marker for squamous cell carcinoma (SCC) of the esophagus.
|
17418617 |
2008 |
|
Esophageal carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the ECRG2 TCA (3)/TCA (4) genotype is associated with the risk of oesophageal carcinoma in a North Indian population.
|
18618216 |
2008 |
|
Malignant neoplasm of esophagus
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In the present study, ECRG2 STR polymorphism was studied in 134 patients with oesophageal cancer and 194 controls, using PCR and polyacrylamide gel electrophoresis.
|
18618216 |
2008 |
|
Malignant neoplasm of esophagus
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Short tandem repeat (STR) polymorphisms in exon 4 of esophageal cancer related gene 2 (ECRG2) are a prognostic marker for squamous cell carcinoma (SCC) of the esophagus.
|
17418617 |
2008 |
|
Esophageal Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The esophageal cancer-related gene 2 (ECRG2) is a novel gene that shows sequence similarity to KAZAL-type serine protease inhibitor.
|
17602171 |
2007 |
|
Esophageal Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Genetically fixed STR polymorphism TCA3/TCA3 in exon 4 of ECRG2 is associated with poor clinical outcome in surgically treated esophageal cancer patients and might be a potential prognostic marker.
|
17693286 |
2007 |
|
Esophageal Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Short tandem repeat (STR) polymorphisms in exon 4 of the Kazal-type esophageal cancer related gene (ECRG2) have been reported to be associated with esophageal carcinoma.
|
17352218 |
2007 |
|
Esophageal Neoplasms
|
0.100 |
GeneticVariation
|
group |
LHGDN |
Genetically fixed STR polymorphism TCA3/TCA3 in exon 4 of ECRG2 is associated with poor clinical outcome in surgically treated esophageal cancer patients and might be a potential prognostic marker.
|
17693286 |
2007 |
|
Esophageal carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Short tandem repeat (STR) polymorphisms in exon 4 of the Kazal-type esophageal cancer related gene (ECRG2) have been reported to be associated with esophageal carcinoma.
|
17352218 |
2007 |